$ABCL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AbCellera Biologics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AbCellera Biologics Inc.. Get notifications about new insider transactions in AbCellera Biologics Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 22 2021 | ABCL | AbCellera Biologic ... | HAMER JOHN | Director | Buy | J | 0.00 | 73,892 | 0 | 73,892 | 0 to 73.9 K |
| Jun 22 2021 | ABCL | AbCellera Biologic ... | HAMER JOHN | Director | Sell | J | 0.00 | 5,000,000 | 0 | 24,105,761 | 29.1 M to 24.1 M (-17.18 %) |
| Jun 16 2021 | ABCL | AbCellera Biologic ... | Lecault Veronique | Chief Operating Off ... | Option Exercise | M | 0.19 | 333,333 | 63,333 | 666,667 | |
| Jun 16 2021 | ABCL | AbCellera Biologic ... | Lecault Veronique | Chief Operating Off ... | Buy | M | 0.19 | 333,333 | 63,333 | 1,339,333 | 1 M to 1.3 M (+33.13 %) |
| Jun 10 2021 | ABCL | AbCellera Biologic ... | Hansen Carl L. G. | Chief Executive Off ... | Sell | S | 25.50 | 401,580 | 10,240,290 | 233,500 | 635.1 K to 233.5 K (-63.23 %) |
| Jun 10 2021 | ABCL | AbCellera Biologic ... | Hansen Carl L. G. | Chief Executive Off ... | Sell | S | 24.03 | 5,598,420 | 134,530,033 | 55,604,330 | 61.2 M to 55.6 M (-9.15 %) |
| Jun 09 2021 | ABCL | AbCellera Biologic ... | Stimart Tryn | Chief Legal Officer | Option Exercise | M | 2.30 | 250,000 | 575,000 | 600,000 | |
| Jun 09 2021 | ABCL | AbCellera Biologic ... | Stimart Tryn | Chief Legal Officer | Option Exercise | M | 0.32 | 750,000 | 240,000 | 1,250,000 | |
| Jun 09 2021 | ABCL | AbCellera Biologic ... | Stimart Tryn | Chief Legal Officer | Buy | M | 2.30 | 250,000 | 575,000 | 1,000,250 | 750.3 K to 1 M (+33.32 %) |
| Jun 09 2021 | ABCL | AbCellera Biologic ... | Stimart Tryn | Chief Legal Officer | Buy | M | 0.32 | 750,000 | 240,000 | 750,250 | 250 to 750.3 K (+300,000.00 %) |
| Apr 23 2021 | ABCL | AbCellera Biologic ... | Falconer Ester | Chief Technology Of ... | Option Exercise | M | 0.03 | 1,000,000 | 34,300 | 0 | |
| Apr 23 2021 | ABCL | AbCellera Biologic ... | Falconer Ester | Chief Technology Of ... | Buy | M | 0.03 | 1,000,000 | 34,300 | 1,000,000 | 0 to 1000 K |
| Apr 23 2021 | ABCL | AbCellera Biologic ... | Falconer Ester | Chief Technology Of ... | Option Exercise | M | 0.03 | 1,000,000 | 34,300 | 0 | |
| Apr 23 2021 | ABCL | AbCellera Biologic ... | Falconer Ester | Chief Technology Of ... | Buy | M | 0.03 | 1,000,000 | 34,300 | 1,000,000 | 0 to 1000 K |
| Dec 17 2020 | ABCL | AbCellera Biologic ... | DCVC Bio, L.P. | 10% Owner | Option Exercise | C | 0.00 | 802,371 | 0 | 0 | |
| Dec 17 2020 | ABCL | AbCellera Biologic ... | DCVC Bio, L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,105,264 | 0 | 0 | |
| Dec 17 2020 | ABCL | AbCellera Biologic ... | DCVC Bio, L.P. | 10% Owner | Buy | C | 0.00 | 29,411 | 0 | 29,105,761 | 29.1 M to 29.1 M (+0.10 %) |
| Dec 17 2020 | ABCL | AbCellera Biologic ... | DCVC Bio, L.P. | 10% Owner | Buy | C | 0.00 | 29,076,350 | 0 | 29,076,350 | 0 to 29.1 M |
| Dec 17 2020 | ABCL | AbCellera Biologic ... | THIEL PETER | Director | Option Exercise | C | 0.00 | 2,924 | 0 | 0 | |
| Dec 17 2020 | ABCL | AbCellera Biologic ... | THIEL PETER | Director | Option Exercise | C | 0.00 | 40,105 | 0 | 0 | |
| Dec 17 2020 | ABCL | AbCellera Biologic ... | THIEL PETER | Director | Option Exercise | C | 0.00 | 334,324 | 0 | 0 | |
| Dec 17 2020 | ABCL | AbCellera Biologic ... | THIEL PETER | Director | Option Exercise | C | 0.00 | 381,126 | 0 | 0 | |
| Dec 17 2020 | ABCL | AbCellera Biologic ... | THIEL PETER | Director | Buy | C | 0.00 | 24,660 | 0 | 24,660 | 0 to 24.7 K |
| Dec 17 2020 | ABCL | AbCellera Biologic ... | THIEL PETER | Director | Buy | C | 0.00 | 382,357 | 0 | 382,357 | 0 to 382.4 K |
| Dec 17 2020 | ABCL | AbCellera Biologic ... | THIEL PETER | Director | Buy | C | 0.00 | 29,240 | 0 | 29,240 | 0 to 29.2 K |
| Dec 17 2020 | ABCL | AbCellera Biologic ... | THIEL PETER | Director | Buy | C | 0.00 | 401,050 | 0 | 401,050 | 0 to 401.1 K |
| Dec 17 2020 | ABCL | AbCellera Biologic ... | THIEL PETER | Director | Buy | C | 0.00 | 3,343,240 | 0 | 3,343,240 | 0 to 3.3 M |
| Dec 17 2020 | ABCL | AbCellera Biologic ... | THIEL PETER | Director | Buy | P | 20.00 | 3,000,000 | 60,000,000 | 10,179,880 | 7.2 M to 10.2 M (+41.78 %) |
| Dec 17 2020 | ABCL | AbCellera Biologic ... | THIEL PETER | Director | Buy | C | 0.00 | 2,477,100 | 0 | 7,179,880 | 4.7 M to 7.2 M (+52.67 %) |
| Dec 17 2020 | ABCL | AbCellera Biologic ... | THIEL PETER | Director | Buy | C | 0.00 | 3,811,260 | 0 | 4,702,780 | 891.5 K to 4.7 M (+427.50 %) |
| Dec 17 2020 | ABCL | AbCellera Biologic ... | HAMER JOHN | Director | Option Exercise | C | 0.00 | 802,371 | 0 | 0 | |
| Dec 17 2020 | ABCL | AbCellera Biologic ... | HAMER JOHN | Director | Option Exercise | C | 0.00 | 2,105,264 | 0 | 0 | |
| Dec 17 2020 | ABCL | AbCellera Biologic ... | HAMER JOHN | Director | Buy | C | 0.00 | 29,411 | 0 | 29,105,761 | 29.1 M to 29.1 M (+0.10 %) |
| Dec 17 2020 | ABCL | AbCellera Biologic ... | HAMER JOHN | Director | Buy | C | 0.00 | 29,076,350 | 0 | 29,076,350 | 0 to 29.1 M |
| Dec 17 2020 | ABCL | AbCellera Biologic ... | Montalbano John S. | Director | Option Exercise | A | 2.41 | 500,000 | 1,205,000 | 500,000 | |
| Dec 17 2020 | ABCL | AbCellera Biologic ... | Montalbano John S. | Director | Buy | P | 20.00 | 5,000 | 100,000 | 5,000 | 0 to 5 K |
| Dec 17 2020 | ABCL | AbCellera Biologic ... | Montalbano John S. | Director | Buy | P | 20.00 | 20,000 | 400,000 | 20,000 | 0 to 20 K |
| Dec 17 2020 | ABCL | AbCellera Biologic ... | Lecault Veronique | Chief Operating Off ... | Option Exercise | A | 20.00 | 190,800 | 3,816,000 | 190,800 | |
| Dec 17 2020 | ABCL | AbCellera Biologic ... | Lecault Veronique | Chief Operating Off ... | Option Exercise | A | 2.41 | 2,000,000 | 4,820,000 | 2,000,000 | |
| Dec 17 2020 | ABCL | AbCellera Biologic ... | Lecault Veronique | Chief Operating Off ... | Buy | P | 20.00 | 17,000 | 340,000 | 61,580 | 44.6 K to 61.6 K (+38.13 %) |
| Dec 17 2020 | ABCL | AbCellera Biologic ... | Lecault Veronique | Chief Operating Off ... | Buy | P | 20.00 | 6,000 | 120,000 | 1,006,000 | 1000 K to 1 M (+0.60 %) |
| Dec 17 2020 | ABCL | AbCellera Biologic ... | Hayden Michael R | Director | Option Exercise | A | 2.76 | 100,000 | 276,000 | 100,000 | |
| Dec 17 2020 | ABCL | AbCellera Biologic ... | Hayden Michael R | Director | Option Exercise | M | 0.33 | 270,000 | 89,100 | 540,000 | |
| Dec 17 2020 | ABCL | AbCellera Biologic ... | Hayden Michael R | Director | Buy | P | 20.00 | 73,665 | 1,473,300 | 118,245 | 44.6 K to 118.2 K (+165.24 %) |
| Dec 17 2020 | ABCL | AbCellera Biologic ... | Hayden Michael R | Director | Buy | C | 0.00 | 117,647 | 0 | 1,103,397 | 985.8 K to 1.1 M (+11.93 %) |
| Dec 17 2020 | ABCL | AbCellera Biologic ... | Hayden Michael R | Director | Buy | M | 0.33 | 270,000 | 89,100 | 985,750 | 715.8 K to 985.8 K (+37.72 %) |
| Dec 17 2020 | ABCL | AbCellera Biologic ... | Stimart Tryn | Chief Legal Officer | Option Exercise | A | 20.00 | 190,800 | 3,816,000 | 190,800 | |
| Dec 17 2020 | ABCL | AbCellera Biologic ... | Stimart Tryn | Chief Legal Officer | Option Exercise | A | 2.41 | 850,000 | 2,048,500 | 850,000 | |
| Dec 17 2020 | ABCL | AbCellera Biologic ... | Stimart Tryn | Chief Legal Officer | Buy | P | 20.00 | 250 | 5,000 | 250 | 0 to 250 |
| Dec 17 2020 | ABCL | AbCellera Biologic ... | Stimart Tryn | Chief Legal Officer | Buy | P | 20.00 | 250 | 5,000 | 250 | 0 to 250 |
Page: 1